Diabetes research is recognized as one of the two strategic areas in the Research Strategic Plan of The University of Oklahoma Health Sciences Center (OUHSC). The major goal of this COBRE is to increase the critical mass of diabetes researchers and improve infrastructure for diabetes research at OUHSC. Our long-term goal is to apply for a NIH P30 Diabetes Research Center (DRC). In the past nine years of COBRE support, we have closely worked with the Harold Hamm Diabetes Center and reached our milestones of Phase I and Phase II. The COBRE has incubated eight NIH R01 grants, two R21s and multiple grants from research foundations such as the American Diabetes Association and the American Heart Association. The Junior Investigators supported by the COBRE have published 207 peer-reviewed papers. Five of the Junior Investigators supported by the COBRE have been promoted to Associate Professors. In addition, the COBRE has recruited four NIH-funded diabetic researchers into OUHSC. The Administrative Core has played a central role in leading COBRE operations and contributed to these achievements. The major goal of this Core in Phase III is to further expand these successes and assist the research Cores to become sustainable research facilities supported by a combination of user fees and institutional resources. In Phase III, the Administrative Core will continue to provide central management of the entire COBRE and coordinate COBRE activities and interactions among all of the COBRE components. The Administrative Core will also facilitate interactions of the Diabetes COBRE with other COBREs and research Centers at OUHSC and throughout the State of Oklahoma. This Core will make an effort to improve the diabetes research environment and facilitate collaborations in diabetes research. This Core will promote resource and data sharing strategies and ensure compliance with human subjects, vertebrate animals and biosafety regulations. This Core will greatly facilitate the continuous growth of the COBRE to achieve its goals.

Public Health Relevance

The major goal of this COBRE is to mentor junior diabetes researchers and improve infrastructure of diabetes research in Oklahoma. The Administrative Core is to provide centralized administration to support the COBRE and increase critical mass of diabetes research in Oklahoma. These efforts will contribute to the prevention and treatment of diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Center Core Grants (P30)
Project #
1P30GM122744-01
Application #
9281486
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2017-07-01
Budget End
2018-06-30
Support Year
1
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Oklahoma Health Sciences Center
Department
Type
DUNS #
878648294
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Wang, Bing; Li, Pui-Kai; Ma, Jian-Xing et al. (2018) Therapeutic Effects of a Novel Phenylphthalimide Analog for Corneal Neovascularization and Retinal Vascular Leakage. Invest Ophthalmol Vis Sci 59:3630-3642
Shin, Younghwa; Moiseyev, Gennadiy; Petrukhin, Konstantin et al. (2018) A novel RPE65 inhibitor CU239 suppresses visual cycle and prevents retinal degeneration. Biochim Biophys Acta Mol Basis Dis 1864:2420-2429
Chen, Jianglei; Fan, Jun; Wang, Shirley et al. (2018) Secreted Klotho Attenuates Inflammation-Associated Aortic Valve Fibrosis in Senescence-Accelerated Mice P1. Hypertension 71:877-885
Chen, Qian; Qiu, Fangfang; Zhou, Kelu et al. (2017) Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPAR?. Diabetes 66:1671-1682
Vanlandingham, Phillip A; Nuno, Didier J; Quiambao, Alexander B et al. (2017) Inhibition of Stat3 by a Small Molecule Inhibitor Slows Vision Loss in a Rat Model of Diabetic Retinopathy. Invest Ophthalmol Vis Sci 58:2095-2105
Malechka, Volha V; Moiseyev, Gennadiy; Takahashi, Yusuke et al. (2017) Impaired Rhodopsin Generation in the Rat Model of Diabetic Retinopathy. Am J Pathol 187:2222-2231
Qiu, Fangfang; Liu, Zhen; Zhou, Yueping et al. (2017) Decreased Circulating Levels of Dickkopf-1 in Patients with Exudative Age-related Macular Degeneration. Sci Rep 7:1263
Pearsall, Elizabeth A; Cheng, Rui; Zhou, Kelu et al. (2017) PPAR? is essential for retinal lipid metabolism and neuronal survival. BMC Biol 15:113
Qiu, Fangfang; Matlock, Greg; Chen, Qian et al. (2017) Therapeutic Effects of PPAR? Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci 58:5065-5075
Deng, Guotao; Moran, Elizabeth P; Cheng, Rui et al. (2017) Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy. Invest Ophthalmol Vis Sci 58:5030-5042

Showing the most recent 10 out of 12 publications